Showing results (11-20 of 731) with videos related to
Sort By:
Pageof 74
The Quarterly Journal of Medicine|April 1, 1989
Quality of life and survival following intensive medical careA Yinnon, A Zimran, C HershkoThe Journal of Rheumatology|December 1, 1986
Hyperkalemia associated with sulindac therapyG Nesher, A Zimran, C HershkoBritish Journal of Haematology|May 1, 1988
The in vivo ageing of red cell enzymes: direct evidence of biphasic decay from polycythaemic rabbits with reticulocytosisA Zimran, S Torem, E BeutlerNephron|January 1, 1988
Reduced incidence of hyperkalemia and azotemia in patients receiving sulindac compared with indomethacinG Nesher, A Zimran, C HershkoActa Neurologica Scandinavica|March 23, 2007
Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease?A Halperin, D Elstein, A ZimranAmerican Journal of Human Genetics|May 1, 1990
Linkage of the PvuII polymorphism with the common Jewish mutation for Gaucher diseaseA Zimran, T Gelbart, E BeutlerClinical Genetics|October 27, 1998
Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher diseaseD Elstein, A Abrahamov, A ZimranAmerican Journal of Clinical Pathology|June 1, 1990
Detection of the 1226 (Jewish) mutation for Gaucher's disease by color PCR. A means for studying the gene frequency of the disorderA Zimran, W C Kuhl, E BeutlerAmerican Journal of Hematology|May 1, 1993
Correction of neutrophil chemotaxis defect in patients with Gaucher disease by low-dose enzyme replacement therapyA Zimran, A Abrahamov, M Aker, et al.Postgraduate Medical Journal|October 3, 2002
Enzyme replacement therapy in the management of longstanding skeletal and soft tissue salmonella infection in a patient with Gaucher's diseaseM Margalit, N Ash, A Zimran, et al.Pageof 74